BMEA
Biomea Fusion, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.01
+4.97%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-268.1%
Return on equity
-88.2%
Return on assets
-446.2%
Return on invested capital
0.00x
Asset turnover
-$47.1M
Cash from operations
$0.48
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026